19 Sep 2022
PBS- 19th September 2022
Confirmed prices reports for brands to be reduced on 1 October 2022 have now been published on the Current Price Disclosure cycle web page. Brand price reduction reports have also been updated following the conclusion of the dispute resolution administrative process.
19 Sep 2022
PBS- 19th September 2022
Confirmed prices reports for brands to be reduced on 1 October 2022 have now been published on the Current Price Disclosure cycle web page. Brand price reduction reports have also been updated following the conclusion of the dispute resolution administrative process.
19 Sep 2022
PBS- 19th September 2022
Confirmed prices reports for brands to be reduced on 1 October 2022 have now been published on the Current Price Disclosure cycle web page. Brand price reduction reports have also been updated following the conclusion of the dispute resolution administrative process.
09 Sep 2022
PBS-9th September 2022
The Public Summary Documents (first time rejections and deferrals) from the May 2022 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available.
09 Sep 2022
PBS-9th September 2022
The Public Summary Documents (first time rejections and deferrals) from the May 2022 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available.
09 Sep 2022
PBS-9th September 2022
The Public Summary Documents (first time rejections and deferrals) from the May 2022 Pharmaceutical Benefits Advisory Committee (PBAC) meeting are now available.
05 Sep 2022
PBS News update- 5 September 2022
The Efficient Funding of Chemotherapy (EFC) Review seeks to investigate current processes involved in the production, distribution and access of chemotherapy and other medicines used for the treatment of cancer, that are provided through the Pharmaceutical Benefits Scheme (PBS)
05 Sep 2022
PBS News update- 5 September 2022
The Efficient Funding of Chemotherapy (EFC) Review seeks to investigate current processes involved in the production, distribution and access of chemotherapy and other medicines used for the treatment of cancer, that are provided through the Pharmaceutical Benefits Scheme (PBS)
05 Sep 2022
PBS News update- 5 September 2022
The Efficient Funding of Chemotherapy (EFC) Review seeks to investigate current processes involved in the production, distribution and access of chemotherapy and other medicines used for the treatment of cancer, that are provided through the Pharmaceutical Benefits Scheme (PBS)
05 Sep 2022
PBS News- 5 September 2022
Collaboration Arrangement between the Department of Health and Aged Care and Health Technology Assessment bodies in the United Kingdom and Canada